This month of May is ALS Awareness Month, and marks an opportune time to spotlight the disease and the importance of ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Dr. Gomez brings extensive neuroscience and orphan disease development experience to Raya as it plans multiple clinical trials in 2026. MONTREAL, QUEBEC, CANADA, May 8, 2025 /EINPresswire.com/ -- Raya ...

Within a couple hours, the bride was doing the limbo under Eby’s walker, and Eby was giving people walker rides all over the ...

Golden said painless progressive weakness is the key to recognizing ALS, and although research still has a long way to go, ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

Eli Lilly (LLY) inks a licensing agreement with Alchemab to jointly develop an ALS drug in a $415M deal. Read more here.

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...

Bradford Smith became the third patient to test Elon Musk's Neuralink — and the first one to do so without a voice.

Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...

Lateral flow tests have transformed global healthcare by enabling rapid disease detection and improving access to medical diagnostics. However, their widespread, single-use design is creating an ...